Primary Site >> Colorectal Cancer
Gene >> CD276
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. PMID: 16713537 |
Ref: Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer. PMID: 17671729 |
Ref: Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. PMID: 20140740 Ref: Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. PMID: 20333377 |
Ref: B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer. PMID: 22473715 Ref: Functional analysis of B7-H3 in colonic carcinoma cells. PMID: 23098490 |
Ref: Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma. PMID: 23981607 |
Ref: Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients. PMID: 24630518 Ref: Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells. PMID: 24892449 Ref: B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome. PMID: 25139714 |
Ref: Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3. PMID: 25684945 Ref: B7H3 promotes cell migration and invasion through the Jak2/Stat3/MMP9 signaling pathway in colorectal cancer. PMID: 26151358 |
Ref: B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway. PMID: 26787540 Ref: B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu. PMID: 27175567 Ref: MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer. PMID: 27329595 Ref: TGF-beta1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis. PMID: 27626488 Ref: Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis. PMID: 28083066 |
Ref: Evaluation of Prognostic Immune Signatures in Patients with Breast, Colorectal and Pancreatic Cancer Receiving Chemotherapy. PMID: 28373465 Ref: Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells. PMID: 28676400 Ref: Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma. PMID: 29113264 |
Ref: Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo. PMID: 29115601 Ref: Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3. PMID: 29710520 Ref: Correlation of IDH1 and B7H3 expression with prognosis of CRC patients. PMID: 29871819 Ref: Molecular imaging of T cell co-regulator factor B7-H3 with (89)Zr-DS-5573a. PMID: 30128047 Ref: Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer. PMID: 30131660 Ref: The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability. PMID: 30288357 |